Pallisgaard, J. L., Lindhardt, T. B., Hansen, M. L., Schjerning, A., Olesen, J. B., Staerk, L., . . . Gislason, G. H. (2015). Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study. PLoS One.
Stile di citazione ChicagoPallisgaard, Jannik Langtved, Tommi Bo Lindhardt, Morten Lock Hansen, Anne-Marie Schjerning, Jonas Bjerring Olesen, Laila Staerk, Christian Torp-Pedersen, e Gunnar Hilmar Gislason. "Cardioversion and Risk of Adverse Events With Dabigatran Versus Warfarin—A Nationwide Cohort Study." PLoS One 2015.
Citazione MLAPallisgaard, Jannik Langtved, et al. "Cardioversion and Risk of Adverse Events With Dabigatran Versus Warfarin—A Nationwide Cohort Study." PLoS One 2015.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.